The Value of Prednisolone With Aspirin Before Embryo Transfer in Intracytoplasmic Sperm Injection (ICSI) Cycles
Status:
Completed
Trial end date:
2018-10-31
Target enrollment:
Participant gender:
Summary
This study is a prospective, double-blind, randomized controlled trial . It includes 250
infertile patients scheduled for ICSI cycle. The patients will be randomly allocated into two
equal groups; daily oral low dose Acetylsalicylic acid and group B patients will receive
daily oral low dose Acetylsalicylic acid and Low dose prednisolone. All 250 participants
undergo similar ICSI cycles. Primary outcome is clinical pregnancy rate per cycle. Secondary
outcomes include number of oocytes retrieved, fertilization rate, number of embryos, embryo
quality, chemical pregnancy rate, twins rate and miscarriage rate per cycle.